Codon-specific translational defect caused by a wobble modification deficiency in mutant tRNA from a human mitochondrial disease.

Point mutations in the mitochondrial (mt) tRNA(Leu(UUR)) gene are responsible for mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS), a subgroup of mitochondrial encephalomyopathic diseases. We previously showed that mt tRNA(Leu(UUR)) with an A3243G or T3271C mutation derived from patients with MELAS are deficient in a normal taurine-containing modification (taum5U; 5-taurinomethyluridine) at the anticodon wobble position. To examine decoding disorder of the mutant tRNA due to the wobble modification deficiency independent of the pathogenic point mutation itself, we used a molecular surgery technique to construct an mt tRNA(Leu(UUR)) molecule lacking the taurine modification but without the pathogenic mutation. This "operated" mt tRNA(Leu(UUR)) without the taurine modification showed severely reduced UUG translation but no decrease in UUA translation. We thus concluded that the UUG codon-specific translational defect of the mutant mt tRNAs(Leu(UUR)) is the primary cause of MELAS at the molecular level. This result could explain the complex I deficiency observed clinically in MELAS.

[1]  P. Agris,et al.  Single atom modification (O-->S) of tRNA confers ribosome binding. , 1999, RNA.

[2]  T Yasukawa,et al.  Wobble modification defect in tRNA disturbs codon–anticodon interaction in a mitochondrial disease , 2001, The EMBO journal.

[3]  D. Turnbull,et al.  Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA , 1999, Nature Genetics.

[4]  K. Nihei,et al.  Respiration-deficient Cells AreCausedbya Single Point Mutation intheMitochondrial tRNA-Leu(UUR)Genein Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, andStrokelike Episodes (MELAS) , 1991 .

[5]  J. Hayashi,et al.  Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[6]  S. Dimauro,et al.  Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA , 1993, Neuromuscular Disorders.

[7]  K. Watanabe,et al.  Interactions of bovine mitochondrial phenylalanyl-tRNA with ribosomes and elongation factors from mitochondria and bacteria. , 1991, Biochimica et biophysica acta.

[8]  J. Speyer,et al.  Synthetic polynucleotides and the amino acid code. IV. , 1962, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Parisi,et al.  Impairment of mitochondrial transcription termination by a point mutation associated with the MELAS subgroup of mitochondrial encephalomyopathies , 1991, Nature.

[10]  S. Kelley,et al.  The pathogenic U3271C human mitochondrial tRNA(Leu(UUR)) mutation disrupts a fragile anticodon stem. , 2003, Nucleic acids research.

[11]  K. Nihei,et al.  A point mutation in the mitochondrial tRNA(Leu)(UUR) gene in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes). , 1990, Biochemical and biophysical research communications.

[12]  Dieter Söll,et al.  Trna: Structure, Biosynthesis, and Function , 1995 .

[13]  Y. Goto,et al.  Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke‐like episodes (MELAS) , 1992, Neurology.

[14]  H. Jacobs,et al.  Disorders of mitochondrial protein synthesis. , 2003, Human molecular genetics.

[15]  V. Ramakrishnan,et al.  Selection of tRNA by the Ribosome Requires a Transition from an Open to a Closed Form , 2002, Cell.

[16]  H. Reichmann,et al.  Pathophysiology of the MELAS 3243 Transition Mutation* , 1997, The Journal of Biological Chemistry.

[17]  M. Zeviani,et al.  Complex I deficiency is associated with 3243G:C mitochondrial DNA in osteosarcoma cell cybrids. , 1996, Human molecular genetics.

[18]  F. Franceschi,et al.  Apparent association constants of tRNAs for the ribosomal A, P, and E sites. , 1992, The Journal of biological chemistry.

[19]  Tsutomu Suzuki,et al.  Defect in modification at the anticodon wobble nucleotide of mitochondrial tRNALys with the MERRF encephalomyopathy pathogenic mutation , 2000, FEBS letters.

[20]  Tsutomu Suzuki,et al.  [Wobble modification defect suppresses translational activity of tRNAs with MERRF and MELAS mutations]. , 2002, Nihon rinsho. Japanese journal of clinical medicine.

[21]  D. Moras,et al.  Crystal structure of yeast tRNAAsp , 1980, Nature.

[22]  L. Spremulli,et al.  Bovine mitochondrial protein synthesis elongation factors. Identification and initial characterization of an elongation factor Tu-elongation factor Ts complex. , 1989, The Journal of biological chemistry.

[23]  J. Ravel,et al.  [32] GTP-dependent binding of aminoacyl-tRNA to Escherichia coli Ribosomes , 1971 .

[24]  D. Wallace,et al.  Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNALys mutation , 1990, Cell.

[25]  A. Rich,et al.  Transfer RNA: molecular structure, sequence, and properties. , 1976, Annual review of biochemistry.

[26]  T. Kaneko,et al.  Wobble modification differences and subcellular localization of tRNAs in Leishmania tarentolae: implication for tRNA sorting mechanism , 2003, The EMBO journal.

[27]  M. King,et al.  Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. , 1989, Science.

[28]  I. Nonaka,et al.  MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Whelan,et al.  HLA-B27 subtypes , 1991, The Lancet.

[30]  K. Watanabe,et al.  Purification and characterization of two serine isoacceptor tRNAs from bovine mitochondria by using a hybridization assay method. , 1989, Nucleic acids research.

[31]  I. Nonaka,et al.  Findings in muscle in complex I (NADH coenzyme Q reductase) deficiency , 1988, Annals of neurology.

[32]  T. Rosenberg,et al.  An mtDNA mutation, 14453G→A, in the NADH dehydrogenase subunit 6 associated with severe MELAS syndrome , 2001, European Journal of Human Genetics.

[33]  Takehiro Yasukawa,et al.  Modification Defect at Anticodon Wobble Nucleotide of Mitochondrial tRNAsLeu(UUR) with Pathogenic Mutations of Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like Episodes* , 2000, The Journal of Biological Chemistry.

[34]  Tsutomu Suzuki,et al.  Taurine as a constituent of mitochondrial tRNAs: new insights into the functions of taurine and human mitochondrial diseases , 2002, The EMBO journal.

[35]  S. Kelley,et al.  Dimerization of a pathogenic human mitochondrial tRNA , 2002, Nature Structural Biology.

[36]  I. Nonaka,et al.  A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies , 1990, Nature.

[37]  J. Goddard,et al.  The structures and functions of transfer RNA. , 1977, Progress in biophysics and molecular biology.

[38]  T Suzuki,et al.  The 'polysemous' codon--a codon with multiple amino acid assignment caused by dual specificity of tRNA identity. , 1997, The EMBO journal.

[39]  P. Agris.  Decoding the genome: a modified view. , 2004, Nucleic acids research.

[40]  G. Keith,et al.  Stepwise degradation of polyribonucleotides. , 1974, Biochemistry.

[41]  S. Dimauro,et al.  Mitochondrial DNA Mutations and Pathogenesis , 1997, Journal of bioenergetics and biomembranes.

[42]  J. Maassen,et al.  Mutation in mitochondrial tRNALeu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness , 1992, Nature Genetics.

[43]  Tsutomu Suzuki,et al.  Identification and Characterization of Mammalian Mitochondrial tRNA nucleotidyltransferases* , 2001, The Journal of Biological Chemistry.

[44]  H. Donis-Keller,et al.  Phy M: an RNase activity specific for U and A residues useful in RNA sequence analysis. , 1980, Nucleic acids research.

[45]  R. Sakuta,et al.  Accumulation of mtDNA with a mutation at position 3271 in tRNA(Leu)(UUR) gene introduced from a MELAS patient to HeLa cells lacking mtDNA results in progressive inhibition of mitochondrial respiratory function. , 1993, Biochemical and biophysical research communications.

[46]  J. Enríquez,et al.  The Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like Episode Syndrome-associated Human Mitochondrial tRNALeu(UUR) Mutation Causes Aminoacylation Deficiency and Concomitant Reduced Association of mRNA with Ribosomes* , 2000, The Journal of Biological Chemistry.

[47]  J. Enríquez,et al.  MtDNA mutation in MERRF syndrome causes defective aminoacylation of tRNALys and premature translation termination , 1995, Nature Genetics.

[48]  Y. Goto,et al.  A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). , 1991, Biochimica et biophysica acta.

[49]  Tsutomu Suzuki,et al.  Translation ability of mitochondrial tRNAsSer with unusual secondary structures in an in vitro translation system of bovine mitochondria , 2001, Genes to cells : devoted to molecular & cellular mechanisms.

[50]  Shigeyuki Yokoyama,et al.  SURVEY AND SUMMARY: Roles of 5-substituents of tRNA wobble uridines in the recognition of purine-ending codons , 2003, Nucleic acids research.